<DOC>
	<DOC>NCT01312909</DOC>
	<brief_summary>The study is designed to see if varenicline combined with age appropriate (adolescent) smoking cessation counseling will help teens quit smoking.</brief_summary>
	<brief_title>Smoking Cessation Study In Healthy Adolescent Smokers</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<criteria>Healthy male and female subjects between the ages of 12 and 19, inclusive. Subjects smoking at least an average of 5 cigarettes per day, motivated to stop smoking, Subjects must have at least one prior failed attempt to quit smoking. Subjects with history, current diagnosis, or treatment of major depression disorder, anxiety disorders, panic disorder, hostility or aggression disorder, perceptual/thinking disturbances, mania, psychosis, bipolar disorder, personality disorder, eating disorder or severe emotional problems (in the past year). Subjects with a prior suicide attempt: subjects hospitalized within the past 12 months due to suicidal ideation or suicidal behavior; subjects considered to have serious suicidal ideation or suicidal behavior in the past 12 months; active suicidal ideation or behavior identified at the screening or baseline visit. Evidence of alcohol and substance abuse/dependence (other than nicotine) within 3 months prior to screening.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>smoking cessation in adolescents</keyword>
</DOC>